Introduction
Artemisinin, isolated from Artemisia annua L. (Asteraceae; commonly known as sweet wormwood), is a sesquiterpene lactone with an endoperoxide bridge effi cient against both the chloroquine-resistant as well as the chloroquinesensitive strains of Plasmodium falciparum and also against cerebral malaria. Currently, the primary method of obtaining artemisinin is by extraction of intact plants. However, yields of the endogenous bioproduction of artemisinin are relatively low (ranging from 0.1 to 0.5% of dry weight), thereby limiting its clinical utilization. It is of great importance to develop a new production method of artemisinin which can provide a stable supply and reduce the cost of artemisinin. Because of successively greater progress in the metabolic engineering of artemisinin production in microbes (Martin et al., 2003; Ro et al., 2006; Anthony et al., 2009) , microbial production of artemisinin may be the method of the future, which can dramatically reduce the cost of artemisinin and thus make artemisinin accessible to most of the people in the world.
The microbes used in the metabolic engineering of artemisinin include Escherichia coli (Martin et al., 2003) , Saccharomyces cerevisiae (Ro et al., 2006) , Aspergillus nidulans (Lubertozzi and Keasling, 2008) and others. S. cerevisiae, an eukaryotic microbe, is an attractive host for the production of artemisinin precursors because it can produce farnesyl pyrophosphate for its sterol biosynthesis. Moreover, S. cerevisiae offers promise for the heterologous expression of genes encoding membrane-bound protein, such as cytochrome P450-encoding genes that hardly have functions in bacterial systems. Engineered yeast can produce on a basis of biomass the 2-to 3-fold amount of artemisinic acid compared to A. annua L. and within a much shorter time (4 -5 days for yeast versus several months for A. annua L.) (Ro et al., 2006) . As such, the productivity of the engineered yeast is nearly two orders of magnitude Amorpha-4,11-diene is the precursor of the antimalarial compound artemisinin. The effect of Vitreoscilla hemoglobin (VHb) and its yeast-conform variant (VHbm) on amorpha-4,11-diene production in engineered Saccharomyces cerevisiae was investigated. First, the VHb gene was mutated to the yeast-conform variant VHbm based on step-by-step extension of a short region of the gene through a series of polymerase chain reactions (PCR). The artifi cial VHbm gene contained codons preferred by the yeast translation machinery. Two yeast expression vectors containing VHb or VHbm gene were constructed and introduced into the amorpha-4,11-diene-producing strain S. cerevisiae WK1 to form WK1 [VHb] and WK1 [VHbm] , respectively. Western blot and CO-difference spectrum absorbance assay showed that VHb and VHbm were successfully expressed. In shake fl asks, VHbm expression conferred higher cell growth than VHb expression. GC-MS results indicated the amorpha-4,11-diene production in WK1 [VHbm] and WK1 [VHb] was 3-and 2-fold higher than that in WK1, respectively. This suggests that VHb might improve the amorpha-4,11-diene production in engineered S. cerevisiae.
higher than that of A. annua L., demonstrating an advantage for the large-scale production of artemisinic acid and other plant terpenes in yeast. In addition, the secretion of artemisinic acid to the medium by the yeast cells simplifi es fractionation and purifi cation of the product, representing another potential cost-saving advantage in industrial processing (Ro et al., 2006) . Therefore, S. cerevisiae was chosen as the preferred host for microbial artemisinin production.
Large-scale production of the compounds of interest often requires the cultivation of genetically engineered microorganisms at high cell densities to maximize the volumetric productivity. Oxygen transfer is one of the key factors affecting growth and productivity in such a process. Oxygen transfer may be improved to a certain extent by the use of high-effi ciency dispersion systems and modifi cation of the growth medium to improve the solubility of oxygen. Alternatively, a metabolic engineering approach may be used, which is based on the observation that the expression of Vitreoscilla hemoglobin (VHb) enhances the growth and products of interest in microorganisms under oxygen-limiting conditions (Suthar and Chattoo, 2006; Chen et al., 2007) .
VHb is an oxygen-binding protein produced by the aerobic bacterium Vitreoscilla stercoraria, which is proposed to enhance the respiration and energy metabolism by promoting oxygen delivery. Through a metabolic engineering strategy, it has been demonstrated that intracellular expression of VHb in a different host circumvented effects of reduced oxygen availability (Wilhelmson et al., 2007) , promoted cell growth (Chen et al., 2007; So et al., 2004) , improved protein expression (Kim et al., 2008; Suthar and Chattoo, 2006) , and elevated chemical production (Chen et al., 2007) .
In the present investigation, the VHb gene was transferred to a yeast strain engineered to produce amorpha-4,11-diene with the aim of enhancement of amorpha-4,11-diene productivity. Moreover, the effect of the yeast-conform variant of the VHb gene, VHb, on the production of amorpha-4,11-diene in a transformed yeast was also investigated.
Material and Methods

Strains and plasmids
Strains and plasmids used in this work are listed in Table I . Escherichia coli strain TG1 was used as a bacterial host for recombinant plasmid amplifi cation. The strain was grown in Luria-
Bacto-yeast extract, 10 g L -1 NaCl) supplemented with ampicillin (100 μg mL -1 ) when required for selection.
The Saccharomyces cerevisiae strain WK1 (MATa; , a derivative of W303-1B, was engineered to produce amorpha-4,11-diene and used as the parent strain for all engineered yeast strains (Kong et al., 2009 ). This strain grows in a non-selective YPD medium (10 g L -1 yeast extract, 20 g L -1 Bacto-peptone, 20 g L -1 glucose). Engineered yeast strains were generally grown at 30 °C in SD medium (0.67% Bacto-yeast nitrogen base with- (Kong et al., 2009 ) was a yeast vector derived from pYeDP60 (Pompon et al., 1996) , in which the GAL10-CYC1 hybrid promoter was replaced with the yeast GAPDH (glyceraldehyde-3-phosphate dehydrogenase isozyme 3) promoter (constitutive).
Enzymes and chemicals
T4 DNA ligase, pMD18-T vector, and restriction enzymes were purchased from Takara Shuzo Co. Ltd. (Kyoto, Japan). EZ-T vector was obtained from GenStar BioSolutions Co. Ltd. (Beijing, China). KOD Plus Taq DNA polymerase was purchased from Toyobo Co. Ltd. (Osaka, Japan). The standard valencene was obtained from Fluka Co. Ltd. (Buchs, Switzerland). All other fi ne chemicals were analytical grade.
Design and synthesis of the VHbm gene
To obtain a high-level expression, a synthetic VHb gene (VHbm) optimized for the heterologous expression in S. cerevisiae was designed. Based on the original DNA sequence of the wildtype gene (GenBank accession no. AF292694), the VHb gene codons were modifi ed to S. cerevisiae-preferred codons with the original protein structure. The table of codon usage in S. cerevisiae can be consulted at http://www.kazusa.or.jp/ codon/cgi-bin/showcodon.cgi?species=4932.
De novo synthesis of the VHbm gene was achieved by successive and overlapping polymerase chain reaction (PCR) using 12 overlapping oligonucleotides (Table II) . Ten of these primers (Fvm1 -5 and Rvm1 -5) were 59 bp in length and with 13 to 27 bp overlap. The detailed procedure was as follows (Fig. 1) . First-round PCR was performed in a total volume of 50 μL containing 1 μL each of primer Fvm1 and Rvm1 (10 μM), 5 μL each of dNTP (2 mM) and 1 μL of KOD Plus DNA polymerase (Toyobo Co. Ltd.). The PCR product was diluted 100 times, and 2 μL of the diluted primary reaction mixture served as template in a secondary amplifi cation round. After six rounds of PCR amplifi cation, the resulting purifi ed 400-bp PCR product was cloned into the EZ-T using Nhe I and BamH I restriction sites to yield the vector pEZVHbm (Fig. 1) . Table II . Primers used in this study.
Primer
Sequences (5'-3') (restriction sites underlined) Restriction enzyme
Plasmid constructions
The VHb gene was amplifi ed by PCR from pSKVHb using the forward primer FVHb harbouring a Nhe I restriction site and the reverse primer RVHb2 containing a BamH I restriction site, and then was directly cloned into pMD18-T to obtain the plasmid pMDVHb (Table I ). The VHb gene was cleaved from pMDVHb with Nhe I/BamH I and cloned into pYeDP60/GAPDH digested by BamH I/Nhe I. The resulting pYeDP60/ The PCR products obtained by amplifi cation with the primer pairs Fvm1 -6/Rvm1 -6; lanes 1 -6, the PCR products amplifi ed by primers Fvm1/Rvm1, Fvm2/Rvm2, Fvm3/Rvm3, Fvm4/Rvm4, Fvm5/Rvm5, Fvm6/ Rvm6, respectively; M, molecular marker DL2000.
VHbm sequence EZ-T 2.7kb
Unauthenticated Download Date | 7/11/17 12:22 AM GAPDH/VHb was a plasmid containing VHb with the GAPDH promoter. Nhe I and BamH I were used to double digest pEZVHbm, and the excised fragment (ca. 0.5 kb) was inserted into the Nhe I and BamH I sites of pYeDP60/GAP-DH to form the recombinant expression vector pYeDP60/GAPDH/VHbm. All clones were sequenced to confi rm the expected sequences.
Transformation of yeast strains
The yeast expression vectors were transformed into S. cerevisiae WK1 by the LiAc/ss -DNA/PEG method according to Gietz et al. (1995) . Two kinds of yeast strains, WK1 [VHb] and WK1 [VHbm] , were constructed in this study. WK1 [VHb] contained the plasmid pYeDP60/GAPDH/VHb, while the strain WK1 [VHbm] was engineered by transformation with pYeDP60/GAPDH/VHbm. Transformants were selected using SD medium without adenine and uracil. Verifi cation of positive clones was done by re-isolation of the plasmids and by colony PCR.
Yeast cultivation and determination of amorpha-4,11-diene
The engineered yeasts were grown in 10 mL liquid SD medium without adenine and uracil for 2 d at 30 °C until the optical density at 600 nm (OD 600 ) reached 1.0. Then 1 mL cell suspension was transferred into 50 mL fresh YPD medium and cultivated for two more days at 30 °C with continuous agitation (200 rpm) until OD 600 reached 2.0. Two mL dodecane (4%, v/v) were added aseptically to the shake fl asks to trap volatile amorpha-4,11-diene. This dodecane layer was sampled for determination of amorpha-4,11-diene production by GC-MS (gas chromatography-mass spectrometry).
Verifi cation of VHb and VHbm expression by Western blot analysis
One mL of S. cerevisiae cells expressing the VHb and VHbm genes were harvested by centrifugation at 12,000 x g for 10 min. The resulting cell pellets were resuspended in 1 mL Y-PER (yeast protein extraction reagent; Thermo Fisher Scientifi c Inc., Waltham, MA, USA) and incubated for 1 h at room temperature to disrupt the cells. After incubation, the debris was removed by centrifugation at 4 °C and 12,000 x g for 10 min).
The resulting supernatant was used directly for protein separation on a 15% polyacrylamide gel, and proteins were transferred onto a PVDFmembrane. A VHb-specifi c rabbit antibody and a horseradish peroxidase (HRP)/goat anti-rabbit IgG conjugate (Amersham-Pharmacia Biotech Europe GmbH, Dübendorf, Switzerland) were used to probe for VHb or VHbm protein bands. An ECL chemiluminescent reagent was used to visualize the antibody-decorated protein band (Amersham-Pharmacia Biotech Europe GmbH).
Analysis of biological activity of VHb and VHbm by CO-difference spectrum absorbance assay
The activity of the expressed VHb and VHbm was detected by CO-difference spectra. One mL cell suspension of WK1 [VHb] , WK1 [VHbm] , and WK1, respectively, was harvested from the culture medium by centrifugation at 12,000 x g for 10 min. The cells were resuspended in 1 mL Y-PER and incubated for 1 h at room temperature. The debris was removed by centrifugation at 4 °C (12,000 x g, 10 min), and the resulting supernatant was used directly for CO-difference spectral analysis using a Spectra Max190 Microplate Spectrophotometer (Molecular Devices, Inc., Sunnyvale, CA, USA).
Analysis of cell growth
Analysis of cell growth was performed in a 250-mL fl ask with a liquid volume of 50 mL. The yeast strains WK1 [VHb] , WK1 [VHbm] , and WK1 were grown in 10 mL liquid SD medium without adenine and uracil for 2 d at 30 °C. Then 1 mL cell suspension was transferred into 50 mL fresh YPD medium and cultivated at 30 °C until stationary phase. Samples of 1 mL were taken at 24-h intervals and OD 600 was measured.
Analysis of amorpha-4,11-diene production in engineered cells
The GC-MS analysis of amorpha-4,11-diene production was performed as previously described (Kong et al., 2009) . GC-MS conditions were as follows: Shimadzu QP2010 system (Kyoto, Japan) equipped with a DB-5 ms column (30 m × 0.25 μm × 0.25 mm); injector temperature, 250 °C; fl ow rate, 2 mL min -1 ; split ratio, 10:1; oven temperature, 100 °C for 2 min, 5 °C min 
Results and Discussion
Synthesis of VHbm gene
The accurate sequence of the synthetic VHbm gene is shown in Fig. 2 . The VHb gene was 441 bp in length and encoded a polypeptide of 147 amino acids. The synonymous codons of the 20 proteinogenic of amino acids (AA) were changed into yeast-preferred codons in the VHbm gene, which can improve the abundance of cognate tRNAs during translation (Table III) . The analysis of the relative adaptiveness (codon usage frequency) of the VHbm and VHb genes was performed with the gcua program (www.gcua.de). In the VHb gene, the relative adaptiveness of 81 codons was 100%, and 66 codons had a relative adaptiveness below 100%, even 26 codons had a relative adaptiveness below 50%. In the VHbm gene, the relative adaptiveness of all codons was 100%. The recombinant vector pEZVHbm was checked by BamH I and Nhe I double digestion.
Construction of plasmids and yeast transformation
Two expression vectors, pYeDP60/GAPDH/ VHb and pYeDP60/GAPDH/VHbm, were constructed for the functional expression of the VHb and the mutated VHbm gene (Fig. 3) . The expression vector pYeDP60/GAPDH/VHbm harboured 
Characterization of VHb and VHbm expression in engineered yeasts
The Western blot results showed that both the VHb and VHbm proteins reacted positively with the VHb-specifi c monoclonal antibody, while no band was observed in the negative control WK1 (Fig. 4A) . Thus the VHb and VHbm proteins were expressed in the yeast cultures.
CO-difference spectrum absorbance analysis of VHb and VHbm activity
The functional expression of VHb and VHbm was confi rmed by their CO-difference spectra. As shown in Fig. 4B , the CO-difference spectra of en- 
Growth of VHb-and VHbm-expressing yeast cells
The VHb and VHbm transformants were grown in shake fl asks to study the VHb effects on cell growth. In the fi rst 24 h, growth of the three strains as monitored by OD 600 was almost identical (Fig. 5) . As expected, the expression of VHb increased the maximum cell density as compared to the control strain. In the two kinds of engineered yeasts, the VHbm strain maintained higher cell growth than the VHb cells during the entire culture period of 168 h. 
Determination of amorpha-4,11-diene in engineered yeasts
Previously, heterologous VHb gene expression had been reported to improve cell growth (Chen et al., 2007; So et al., 2004) and production of heterologous proteins and biomass (Kim et al., 2008; Suthar and Chattoo, 2006) . With the aim of improving the amorpha-4,11-diene production, the VHb gene from Vitreoscilla was introduced into S. cerevisiae engineered to produce amorpha-4,11-diene. To determine the effect of VHb expression on amorpha-4,11-diene production, three positive clones of WK1 [VHb] were cultured for product determination by GC-MS. As the control, three clones of WK1 containing the ADS gene only were also cultured and analysed by GC-MS. A standard curve for valencene was used for the quantifi cation of amorpha-4,11-diene. The positive clones all produced amorpha-4,11-diene (Fig. 6) , and the production of amorpha-4,11-diene produced by the strain containing the VHb gene was two times greater than that in the VHb non-expressing WK1 (Table IV) .
It is well known that there is a strong correlation between the gene expression level and the degree of biased codon usage. Therefore, this work investigated whether codon usage indeed controls gene expression. The full VHb cDNA was rewritten according to the S. cerevisiae-preferred codon usage. The identity of amino acid sequences encoded by the two genes was 100%, while it was only 84.58% at the nucleic acid level. The GC-MS data indicated that the production of amorpha-4,11-diene in the engineered yeasts containing the VHbm gene is higher than that of the control not harbouring the VHb gene (Table  IV) . These results indicated the rewriting of the VHb gene can increase the amorpha-4,11-diene production. 
